US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 63.750
  • +0.360+0.57%
Trading Nov 19 15:54 ET
197.66BMarket Cap30.72P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
10.65%1.83B
14.80%2.4B
23.78%2.8B
175.85%6.9B
15.30%897M
78.98%1.65B
745.34%2.09B
309.04%2.26B
1,043.77%2.5B
222.33%778M
Other non cash items
220.23%839M
73.76%702M
-150.70%-356M
127.07%1.45B
142.04%927M
58.79%262M
308.08%404M
-1,675.00%-142M
-52.38%639M
-49.41%383M
Change In working capital
-95.43%41M
86.96%-129M
-288.02%-455M
-92.01%300M
-49.83%150M
-15.93%897M
-268.48%-989M
-86.59%242M
85.90%3.76B
811.90%299M
-Change in receivables
----
----
----
-5.63%-1.43B
----
----
----
----
-40.37%-1.35B
----
-Change in inventory
----
----
----
-116.98%-669M
----
----
----
----
149.90%3.94B
----
Cash from discontinued investing activities
Operating cash flow
8.64%3.38B
79.57%3.09B
-20.65%2.49B
5.48%10.35B
-0.75%2.38B
6.28%3.11B
37.66%1.72B
-3.06%3.13B
64.48%9.81B
69.11%2.4B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-32.80%-417M
-42.01%-382M
-198.36%-364M
-51.92%-1.23B
-389.72%-524M
-36.52%-314M
-6.32%-269M
44.29%-122M
24.95%-809M
66.56%-107M
Net intangibles purchase and sale
-62.32%-909M
-51.32%-286M
-16.06%-1.11B
-105.81%-2.13B
-136.16%-418M
35.19%-560M
18.88%-189M
-497.93%-959M
-97.89%-1.03B
54.85%-177M
Net business purchase and sale
-2.93%-281M
-1,221.74%-2.43B
-120.66%-940M
-11.12%-1.18B
-56.61%-296M
20.18%-273M
36.11%-184M
-76.03%-426M
88.75%-1.06B
13.30%-189M
Net investment purchase and sale
111.04%18M
109.09%115M
-568.42%-89M
94.02%-7M
-56.84%82M
49.54%-163M
266.67%55M
-61.22%19M
-48.10%-117M
2,211.11%190M
Net other investing changes
----
----
----
--190M
--0
--15M
--0
--175M
----
----
Cash from discontinued investing activities
Investing cash flow
-24.00%-1.51B
-452.31%-2.87B
-93.66%-2.41B
-37.30%-4.06B
-332.53%-1.08B
29.95%-1.22B
35.00%-520M
-641.67%-1.25B
73.23%-2.96B
72.73%-249M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
-100.08%-2.42B
21.20%-1.13B
211.10%5.97B
19.38%-965M
24.84%-236M
-2,184.48%-1.21B
-16.24%-1.44B
546.13%1.92B
-115.16%-1.2B
63.19%-314M
Net common stock issuance
-2,025.00%-77M
25.00%5M
50.00%6M
13.79%33M
16.67%21M
33.33%4M
33.33%4M
-20.00%4M
0.00%29M
-5.26%18M
Cash dividends paid
-11.77%-1.58B
22.73%-17M
0.46%-3.03B
-2.68%-4.48B
---2M
-1.22%-1.41B
---22M
-2.56%-3.05B
-13.17%-4.36B
--0
Net other financing activities
152.17%24M
--0
-0.12%-841M
15.38%-886M
--0
8.00%-46M
--0
15.75%-840M
-488.20%-1.05B
--0
Cash from discontinued financing activities
Financing cash flow
-51.54%-4.13B
19.55%-1.22B
199.85%2.03B
3.75%-6.57B
18.72%-291M
-90.63%-2.73B
-17.30%-1.52B
45.70%-2.03B
-286.98%-6.82B
65.94%-358M
Net cash flow
Beginning cash position
22.04%6.68B
31.98%7.69B
-5.78%5.64B
-0.91%5.98B
10.34%4.62B
22.12%5.47B
8.87%5.83B
-0.91%5.98B
-19.98%6.04B
-36.32%4.19B
Current changes in cash
-171.55%-2.26B
-214.33%-1.01B
1,559.03%2.1B
-1,244.00%-286M
-43.50%1.01B
-242.80%-833M
62.10%-321M
78.70%-144M
101.73%25M
428.02%1.79B
Effect of exchange rate changes
205.26%20M
83.33%-6M
-318.18%-46M
25.00%-60M
0.00%6M
62.75%-19M
-38.46%-36M
-22.22%-11M
-29.03%-80M
-45.45%6M
End cash Position
-3.98%4.44B
22.04%6.68B
31.98%7.69B
-5.78%5.64B
-5.78%5.64B
10.34%4.62B
22.12%5.47B
8.87%5.83B
-0.91%5.98B
-0.91%5.98B
Free cash flow
-9.40%2.03B
95.71%2.42B
-47.02%881M
-9.26%6.57B
-22.23%1.43B
22.87%2.24B
75.18%1.24B
-42.04%1.66B
92.32%7.24B
163.43%1.84B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations 10.65%1.83B14.80%2.4B23.78%2.8B175.85%6.9B15.30%897M78.98%1.65B745.34%2.09B309.04%2.26B1,043.77%2.5B222.33%778M
Other non cash items 220.23%839M73.76%702M-150.70%-356M127.07%1.45B142.04%927M58.79%262M308.08%404M-1,675.00%-142M-52.38%639M-49.41%383M
Change In working capital -95.43%41M86.96%-129M-288.02%-455M-92.01%300M-49.83%150M-15.93%897M-268.48%-989M-86.59%242M85.90%3.76B811.90%299M
-Change in receivables -------------5.63%-1.43B-----------------40.37%-1.35B----
-Change in inventory -------------116.98%-669M----------------149.90%3.94B----
Cash from discontinued investing activities
Operating cash flow 8.64%3.38B79.57%3.09B-20.65%2.49B5.48%10.35B-0.75%2.38B6.28%3.11B37.66%1.72B-3.06%3.13B64.48%9.81B69.11%2.4B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale -32.80%-417M-42.01%-382M-198.36%-364M-51.92%-1.23B-389.72%-524M-36.52%-314M-6.32%-269M44.29%-122M24.95%-809M66.56%-107M
Net intangibles purchase and sale -62.32%-909M-51.32%-286M-16.06%-1.11B-105.81%-2.13B-136.16%-418M35.19%-560M18.88%-189M-497.93%-959M-97.89%-1.03B54.85%-177M
Net business purchase and sale -2.93%-281M-1,221.74%-2.43B-120.66%-940M-11.12%-1.18B-56.61%-296M20.18%-273M36.11%-184M-76.03%-426M88.75%-1.06B13.30%-189M
Net investment purchase and sale 111.04%18M109.09%115M-568.42%-89M94.02%-7M-56.84%82M49.54%-163M266.67%55M-61.22%19M-48.10%-117M2,211.11%190M
Net other investing changes --------------190M--0--15M--0--175M--------
Cash from discontinued investing activities
Investing cash flow -24.00%-1.51B-452.31%-2.87B-93.66%-2.41B-37.30%-4.06B-332.53%-1.08B29.95%-1.22B35.00%-520M-641.67%-1.25B73.23%-2.96B72.73%-249M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt -100.08%-2.42B21.20%-1.13B211.10%5.97B19.38%-965M24.84%-236M-2,184.48%-1.21B-16.24%-1.44B546.13%1.92B-115.16%-1.2B63.19%-314M
Net common stock issuance -2,025.00%-77M25.00%5M50.00%6M13.79%33M16.67%21M33.33%4M33.33%4M-20.00%4M0.00%29M-5.26%18M
Cash dividends paid -11.77%-1.58B22.73%-17M0.46%-3.03B-2.68%-4.48B---2M-1.22%-1.41B---22M-2.56%-3.05B-13.17%-4.36B--0
Net other financing activities 152.17%24M--0-0.12%-841M15.38%-886M--08.00%-46M--015.75%-840M-488.20%-1.05B--0
Cash from discontinued financing activities
Financing cash flow -51.54%-4.13B19.55%-1.22B199.85%2.03B3.75%-6.57B18.72%-291M-90.63%-2.73B-17.30%-1.52B45.70%-2.03B-286.98%-6.82B65.94%-358M
Net cash flow
Beginning cash position 22.04%6.68B31.98%7.69B-5.78%5.64B-0.91%5.98B10.34%4.62B22.12%5.47B8.87%5.83B-0.91%5.98B-19.98%6.04B-36.32%4.19B
Current changes in cash -171.55%-2.26B-214.33%-1.01B1,559.03%2.1B-1,244.00%-286M-43.50%1.01B-242.80%-833M62.10%-321M78.70%-144M101.73%25M428.02%1.79B
Effect of exchange rate changes 205.26%20M83.33%-6M-318.18%-46M25.00%-60M0.00%6M62.75%-19M-38.46%-36M-22.22%-11M-29.03%-80M-45.45%6M
End cash Position -3.98%4.44B22.04%6.68B31.98%7.69B-5.78%5.64B-5.78%5.64B10.34%4.62B22.12%5.47B8.87%5.83B-0.91%5.98B-0.91%5.98B
Free cash flow -9.40%2.03B95.71%2.42B-47.02%881M-9.26%6.57B-22.23%1.43B22.87%2.24B75.18%1.24B-42.04%1.66B92.32%7.24B163.43%1.84B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Infectious Disease
Infectious Disease
Intraday-0.30%